<DOC>
	<DOCNO>NCT00790283</DOCNO>
	<brief_summary>The purpose study Evaluate Short-Term Mid-Term Safety Efficacy NUMEN Cobalt-Chromium coronary stent treatment de novo lesion native coronary artery compare VISION/MINIVISION coronary stent</brief_summary>
	<brief_title>Assessment Numen Stent With Evaluation Randomized Study</brief_title>
	<detailed_description>The success bare metal coronary stenting limited restenosis phenomenon , rate depend patient vascular morphology lesion-related factor , indication technique stent deployment , others . Drug-eluting stent ( DES ) improve treatment many coronary artery lesion significantly reduce in-stent restenosis . However , numerous limitation result need long-term dual antiplatelet therapy , consequent bleeding risk ( old patient , surgery , colon gastric cancer , trauma ) , unknown side-effects long-term antiplatelet therapy , cost associate long-term thienopyridine regimen , body 's reaction stent polymer , 0.2 % per year increase late stent thrombosis comparison bare metal stent ( BMS ) . For reason , continuous research devote improve effectiveness bare metal stent . The ideal stent non-thrombogenic , low rate restenosis late thrombotic event . The NUMEN stent design meet criterion , use extremely low stent strut thickness .</detailed_description>
	<criteria>Age &gt; 18 year Clinical instrumental documentation stable/unstable myocardial ischemia angina &gt; 50 % lesion major coronary vessel and/or side branch &gt; 2.0 mm Lesion length ≤ 20 mm Vessel require stent size diameter ≥ 2.5 mm Age &lt; 18 year Life expectancy &lt; 6 month Chronic renal failure ( serum creatinine &gt; 2 mg % ) Ongoing acute myocardial infarction Left ventricular ejection fraction ( LVEF ) &lt; 30 % Cardiogenic shock Documented suspect systemic and/or infectious disease Hypersensitivity cobalt chromium contrast medium Antithrombotic drug intolerance Cardiac and/or extracardiac document disease require surgical repair Patient acceptable candidate emergent coronary artery bypass surgery Primary secondary pulmonary hypertension ( echodoppler ) Planned &gt; 2 stent implantation ( except bailout ) Recent ( &lt; 6 month ) PCI CABG Other type stent implantation ( also case bailout ) Visible endocoronary thrombosis Diffuse , severe coronary calcification Use debulking device Extreme vessel tortuosity Unprotected leave main stenosis ( ULM ) Bifurcation lesion In stent restenosis ( ISR ) Saphenous vein graft ( SVG ) arterial pas ( internal mammary artery , IMA ) Chronic total occlusion ( CTO )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>Treatment de novo lesion native coronary artery</keyword>
</DOC>